Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q4 FY26 results · Jan–Mar 2026
Unichem Laboratories reported revenue from operations of ₹575.12 crore (down 2.1% from Q4 FY25) and net profit of ₹10.91 crore (down 79.4% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 575.12 | 587.18 | −2.1% | 521.17 | +10.4% |
| Other income | 23.47 | 9.25 | +153.7% | 11.80 | +98.9% |
| Total income | 598.59 | 596.43 | +0.4% | 532.97 | +12.3% |
| Profit before tax | 18.79 | 57.80 | −67.5% | 293.43 | −93.6% |
| Net profit for the period | 10.91 | 52.97 | −79.4% | 264.29 | −95.9% |
| EPS, basic (₹) | 1.55 | 7.52 | −79.4% | 37.54 | −95.9% |
| Net margin (%) | 1.9 | 9.0 | 50.7 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 356.24 | 461.24 | −22.8% | 314.90 | +13.1% |
| Other income | 22.22 | 6.05 | +267.3% | 15.03 | +47.8% |
| Total income | 378.46 | 467.29 | −19.0% | 329.93 | +14.7% |
| Profit before tax | (10.71) | 56.03 | Turned loss | 259.82 | Turned loss |
| Net profit for the period | (15.39) | 51.22 | Turned loss | 216.11 | Turned loss |
| EPS, basic (₹) | (2.19) | 7.28 | Turned loss | 30.69 | Turned loss |
| Net margin (%) | -4.3 | 11.1 | 68.6 |
Consolidated
- Filed with BSE
- 22 May 2026, 17:56 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 May 2026, 17:56 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE